FDA Public Meeting: Rare Disease Day 2022
FDA will host a virtual public meeting on March 4, 2022 to join the global observance of Rare Disease Day. The theme for FDA’s Rare
June 23, 2025
No Comments
Blog Posts
CAC2 Webinar–“Beyond the Signature: Demystifying Informed Consent in Childhood Cancer”
In CAC2’s June webinar, “Beyond the Signature: Demystifying Informed Consent in Childhood Cancer,” we brought together an extraordinary panel of experts, including a clinical ethicist,
June 5, 2025
No Comments
Blog Posts
CAC2 Webinar–“Fertility Hope for Childhood Cancer Survivors”
In CAC2’s May webinar, “Fertility Hope for Childhood Cancer Survivors” our speakers explored fertility preservation and future family building options for childhood cancer patients and
May 19, 2025
No Comments
CAC2 Drop-In Session–“Know Before You Go, Preparing to Attend the CAC2 Summit in June”
If you weren’t able to join us for the “Know Before You Go” drop-in session for CAC2 Members it isn’t too late to catch up
May 9, 2025
No Comments
Blog Posts
CAC2 Webinar–“Patient Advocacy, Non-Profit Foundations, and the Changing Landscape of Pediatric Cancer Funding”
In CAC2’s April pop-up webinar, “Patient Advocacy, Non-Profit Foundations, and the Changing Landscape of Pediatric Cancer Funding,” our special guest, Dr. Kimryn Rathmell, shared compelling
April 30, 2025
No Comments
Blog Posts
CAC2 Webinar–“The Role of AI from Diagnosis to Treatment for Childhood Cancer”
In CAC2’s April webinar, “The Role of AI from Diagnosis to Treatment for Childhood Cancer,” our speakers explored how Artificial Intelligence is being used in
April 21, 2025
No Comments
Blog Posts
CAC2 Webinar–“Fit for Filing”
In CAC2’s “Fit for Filing” webinar, our speakers explored designing and conducting academic or academic industry collaborative trials that produce data suitable for regulatory filing.
January 20, 2025
No Comments
Blog Posts
Guest Blog–Conversations on Cancer – Pediatric Cancers: Navigating the Challenges Together
In conjunction with the European Medicines Agency (EMA), the FDA Oncology Center of Excellence (OCE) held a one-hour Conversations on Cancer public panel discussion on
November 19, 2024
No Comments
CAC2 News
CAC2 Webinar–Hearing Loss from Cisplatin—Multiple Perspectives on the New FDA Preventative Treatment Option
Children who receive cisplatin as part of their cancer treatment are at risk for progressive and/or permanent hearing loss as a result of their treatment.
December 1, 2022
No Comments
Blog Posts
Guest Blog–The Fit for Filing Group at ACCELERATE
Blogged with permission and thanks by the ACCELERATE Fit for Filing Working Group The ACCELERATE PLATFORM’S Fit for Filing (FFF) group was formed in 2019 to explore
November 14, 2022
No Comments